← Back

ACT EU - Accelerating Clinical Trials · EU-wide · 8 May 2026 · Guidance

ACT EU: Support for non-commercial sponsors

AI-generated summary

The ACT EU initiative identifies barriers preventing non-commercial sponsors from conducting clinical trials in the EU/EEA. It will establish an action plan including regulatory helpdesks for Clinical Trials Regulation questions, define non-commercial sponsors, and organize workshops on prioritized topics through a multi-stakeholder platform.

From ACT EU - Accelerating Clinical Trials

The ACT EU initiative aims to identify gaps, issues and bottlenecks (regulatory, resourcing, operational) that prevent non-commercial sponsors from setting up and conducting clinical trials and multinational trials in particular.

The programme intends to establish an action plan with clear measures in place to support non-commercial sponsors across the European Union / European Economic Area by:

- creating and maintaining a network of regulatory helpdesks, building on national activities, including extra support for questions on the Clinical Trials Regulation and the Clinical Trials Information System;

- finalising a definition of non-commercial sponsors;

- organising dedicated workshops, in liaison with the ACT EU Multi-stakeholder platform advisory group, to address prioritised topics.

Excerpt from the official page. The original is authoritative.